These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1872925)

  • 21. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects.
    Dart AM; Riemersma RA; Oliver MF
    Atherosclerosis; 1989 Dec; 80(2):119-24. PubMed ID: 2692571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM.
    Morgan WA; Raskin P; Rosenstock J
    Diabetes Care; 1995 Jan; 18(1):83-6. PubMed ID: 7698053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
    Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W
    Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of n-3 fatty acids on serum lipids and glycaemic control.
    Eritsland J; Seljeflot I; Abdelnoor M; Arnesen H; Torjesen PA
    Scand J Clin Lab Invest; 1994 Jul; 54(4):273-80. PubMed ID: 7939369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
    Avogaro A; Piliego T; Catapano A; Miola M; Tiengo A
    Acta Diabetol; 1999 Jun; 36(1-2):27-33. PubMed ID: 10436249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Diabetes Care; 1997 Jun; 20(6):913-21. PubMed ID: 9167099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.
    Glauber H; Wallace P; Griver K; Brechtel G
    Ann Intern Med; 1988 May; 108(5):663-8. PubMed ID: 3282462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
    Schectman G; Kaul S; Kissebah AH
    Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels.
    Layne KS; Goh YK; Jumpsen JA; Ryan EA; Chow P; Clandinin MT
    J Nutr; 1996 Sep; 126(9):2130-40. PubMed ID: 8814201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.
    Axelrod L; Camuso J; Williams E; Kleinman K; Briones E; Schoenfeld D
    Diabetes Care; 1994 Jan; 17(1):37-44. PubMed ID: 8112187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish oil in diabetic nephropathy.
    Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
    Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease.
    Reis GJ; Silverman DI; Boucher TM; Sipperly ME; Horowitz GL; Sacks FM; Pasternak RC
    Am J Cardiol; 1990 Nov; 66(17):1171-5. PubMed ID: 2239719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.
    Connor WE; DeFrancesco CA; Connor SL
    Ann N Y Acad Sci; 1993 Jun; 683():16-34. PubMed ID: 8352438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study.
    Wilt TJ; Lofgren RP; Nichol KL; Schorer AE; Crespin L; Downes D; Eckfeldt J
    Ann Intern Med; 1989 Dec; 111(11):900-5. PubMed ID: 2683921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fish oil supplementation attenuates changes in plasma lipids caused by dexamethasone treatment in rats.
    Barbosa AM; Francisco Pde C; Motta K; Chagas TR; Dos Santos C; Rafacho A; Nunes EA
    Appl Physiol Nutr Metab; 2016 Apr; 41(4):382-90. PubMed ID: 26939043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.